Statement of Changes in Beneficial Ownership (4)
February 24 2023 - 5:35PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
DUNLEVIE BRUCE |
2. Issuer Name and Ticker or Trading Symbol
1Life Healthcare Inc
[
ONEM
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
C/O BENCHMARK, 2965 WOODSIDE ROAD |
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/22/2023 |
(Street)
WOODSIDE, CA 94062
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 2/22/2023 | | D | | 12586.00 | D | $18.00 (1) | 0.00 | D | |
Common Stock | 2/22/2023 | | D | | 665257.00 | D | $18.00 (1) | 0.00 | I | See Footnote (2) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (Right to Buy) | $29.00 | 2/22/2023 | | D | | | 5294.00 | (4) | 5/13/2030 | Common Stock | 5294.00 | (3) | 0.00 | D | |
Stock Option (Right to Buy) | $40.55 | 2/22/2023 | | D | | | 498.00 | (4) | 7/14/2030 | Common Stock | 498.00 | (3) | 0.00 | D | |
Stock Option (Right to Buy) | $30.48 | 2/22/2023 | | D | | | 1014.00 | (4) | 10/14/2030 | Common Stock | 1014.00 | (3) | 0.00 | D | |
Stock Option (Right to Buy) | $42.68 | 2/22/2023 | | D | | | 725.00 | (4) | 1/14/2031 | Common Stock | 725.00 | (3) | 0.00 | D | |
Stock Option (Right to Buy) | $42.70 | 2/22/2023 | | D | | | 718.00 | (4) | 4/14/2031 | Common Stock | 718.00 | (3) | 0.00 | D | |
Restricted Stock Units | (5) | 2/22/2023 | | D | | | 20728.00 | (6) | (6) | Common Stock | 20728.00 | (6) | 0.00 | D | |
Explanation of Responses: |
(1) | Reflects disposition of Issuer common stock with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the
"Merger Agreement"), dated as of July 20, 2022, by and among Issuer, Amazon.com, Inc. ("Parent") and Negroni Merger Sub, Inc., a wholly
owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger (the "Merger") between Issuer and Merger Sub on
February 22, 2023. Pursuant to the Merger Agreement, as of the effective time of the Merger (the "Effective Time"), each share of Issuer
common stock, par value $0.001 per share ("Shares") issued and outstanding immediately prior to the Effective Time was converted
automatically into the right to receive $18.00 in cash, without interest (the "Merger Consideration"). |
(2) | Shares owned directly by entities controlled by Reporting Person. |
(3) | Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per
Share that is greater than the Merger Consideration was canceled without the payment of consideration. |
(4) | The shares subject to the option are fully vested and immediately exercisable. |
(5) | Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. RSUs convert into the
issuer's common stock on a one-for-one basis. |
(6) | The RSUs vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. At the Effective Time, each outstanding RSU that was unvested was accelerated in full and was automatically converted in to the right to receive the Merger Consideration. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
DUNLEVIE BRUCE C/O BENCHMARK 2965 WOODSIDE ROAD WOODSIDE, CA 94062 | X |
|
|
|
Signatures
|
/s/ Ivy Tseng, Attorney-in-Fact for Bruce Dunlevie | | 2/24/2023 |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1Life Healthcare (NASDAQ:ONEM)
Historical Stock Chart
From Oct 2024 to Nov 2024
1Life Healthcare (NASDAQ:ONEM)
Historical Stock Chart
From Nov 2023 to Nov 2024